Why I'm Over the Moon for This Healthcare Stock -- In One Chart
With 7% of the Medicare budget spent on dialysis for chronic kidney failure patients despite representing only 1% of the Medicare population, there is a compelling reason to seek innovative solutions.
The U.S. dialysis market is expected to grow 30% by 2030 as a result of an aging population coupled with increased rates of diabetes, hypertension, and obesity. That means more medical transport to dialysis centers, more equipment and seats needed at those centers, and more staff to provide care. This sets up innovative companies like Outset Medical (NASDAQ: OM) nicely.
Source Fool.com
